Correction to Bristol-Myers Squibb Article
13 August 2015 - 9:35AM
Dow Jones News
The name of Bristol-Myers Squibb Co.'s cancer drug is Opdivo.
"FDA Pushes Back Decision on Expanded Use of Bristol-Myers Squibb
Drug Opdivo, " at 5:06 p.m. EDT, incorrectly stated the name of the
drug in the headline. (Aug. 12, 2015)
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2024 to May 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From May 2023 to May 2024